At the news
? BULLISHIMPACT 7/10 6-K filed Jul 9, 2026 at 21:33 ET
Mesoblast reported Ryoncil net revenue of US$36M for Q4 and US$115M for FY2026 ending June 30, 2026. The filing is a preliminary estimate subject to audit, and management guided for continued revenue growth. The company also noted a strong capital position and a new five-year facility.
- Ryoncil net revenue of US$36 million for Q4 FY2026 (quarter ended June 30, 2026)
- Full-year FY2026 Ryoncil net revenue of US$115 million
- Results are preliminary estimates, subject to completion of year-end closing and audit procedures
- Management anticipates continued revenue growth in the coming fiscal year
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access